Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy With TACE and Adefovir Compared With TACE Alone for HBV-related Unresectable Hepatocellular Carcinoma

NCT00960518 is registered in ClinicalTrials.gov with Tongji University as lead sponsor.

NCT NCT00960518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00960518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy With TACE and Adefovir Compared With TACE Alone for HBV-related Unresectable Hepatocellular Carcinoma
Lead sponsor
Tongji University
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2009
Completion date
August 31, 2015
Enrollment
216 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b virus, hepatocellular carcinoma